Company intelligence / Profile preview
Neobiosis
Gainesville, Florida, United Statesneobiosis.com ↗
- Ownership
- Private
- Employees
- ~23
- Development stage
- Phase 1
01
Overview
Neobiosis has received FDA IND approval to begin clinical trials with its ViXome™ product targeting post acute COVID‑19 syndrome ("long COVID"). Another program, VIX‑001, has entered Phase 1 trials targeting neurologic manifestations. The company’s approach leverages perinatal tissue-derived biologics—cells and extracellular vesicles—for regenerative medicine applications. No published late-stage clinical results yet; programs are early-stage but advancing through regulatory milestones.
- Therapeutic areas
- OtherNeurologyInfectious Diseases
- Modalities
- Cell therapyExtracellular vesicle-based therapy (EVs)BiologicPerinatal tissue-derived therapeuticsMatrix-based regenerative products
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Collaborations with University of Florida/Sid Martin Innovate Biotechnology Center for R&D facilities; no major pharma partnerships publicly listed.
Beyond the preview
Go deeper on Neobiosis.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Neobiosis.